All News

Patients who had low levels of vitamin D before starting chemotherapy tended to have higher rates of chemotherapy-induced peripheral neuropathy, but more research is needed in this field.

Here are ways to become a patient advocate.

Patients with advanced clear cell renal cell carcinoma treated with zanzalintinib had experienced promising antitumor activity with manageable toxicity regardless of prior treatment with cabozantinib.

Researchers continue to investigate novel immunotherapy drugs for the treatment of renal cell carcinoma.

After receiving a cancer diagnosis, it stays with you 24/7.

While CAR-T cell therapy is showing promise in treating patients with advanced renal cell carcinoma, there is still more research that needs to be done in this arena.

Although research has delved into the potential link between clonal hematopoiesis and heart-related events such as heart attacks and strokes in patients with kidney cancer, more research is needed to further understand this association.

Older adults with late stage cancer often prioritize quality of life and independence over survival time, which may change their treatment plan, an expert said.

I was in denial after the shock of being told I had prostate cancer.

Circulating tumor DNA — which is observed via blood test — may be helpful in determining which patients with kidney cancer need more intense treatment and who can have their therapies deescalated.

Last week’s oncology headlines focused on veterans with cancer, as well as FDA regulatory decisions and an expert’s opinion on what patients need to consider when choosing a Medicare plan.

Researchers found that some caregivers face racism and discrimination as they care for loved ones with cancer.

Most patients with cancer may not be discussing the cost of care with their clinicians, according to recent research.

Patients with prostate cancer who receive docetaxel with standard-of-care treatment may have a reduced risk of death and an improved prognosis, according to a recent study.

Up to a quarter of patients with breast cancer face financial burden due to the cost of supplements, complimentary therapy and alternative medicines which “may decrease adherence to prescribed medications,” researchers found.

A phase 3 trial found that testosterone recovery after androgen deprivation therapy leads to better quality of life following high-risk prostate cancer.

While translocation renal cell carcinoma tends to respond well to immunotherapy, there is still a need for more investigation into targeted therapies for this patient population.

U.S. Army Reserve Veteran and stage 3 colon cancer survivor discussed the significance of the 2022 passage of the PACT Act and what it means for veterans facing cancer.

My donor is at war.

From actor Patrick Dempsey saying that his late mother would be proud of his work at The Dempsey Center to a “General Hospital” actor discussing his cancer treatments, here’s what’s happening in the oncology space this week.

It is essential for patients who receive immune checkpoint inhibitors to actively communicate with their care teams when experiencing symptoms, an expert explained.

CURE® highlights some of the most significant lung cancer news of 2023 in honor of Lung Cancer Awareness Month.

An expert explained the different treatment options for patients with estrogen receptor-positive, HER2-negative breast cancer that has recently been diagnosed or has recurred.

An expert reflects on the recent FDA approval of adjuvant Opdivo for patients with stage 2B or 2C melanoma.

Sometimes after a diagnosis of cancer, plans and attending events can become elusive due to symptoms and treatments.

The Food and Drug Administration revised the existing approval of Keytruda, Herceptin and chemotherapy for patients with unresetable or metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Patients with metastatic colorectal cancer are eligible for treatment with Fruzaqla, an oral targeted therapy, following treatment via fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapy as well as an anti-VEGF therapy, and, if their disease RAS wild-type and medically appropriate, an anti-EGFR therapy.

Oncology telehealth services became more popular during the COVID-19 pandemic and remain to be important for patients with cancer, according to a recent survey.

This November, our country celebrates 76 years of Veteran’s Day, and we want to increase awareness of veterans with lung cancer in this special issue of CURE.